TG Therapeutics, Inc. Opens Expansion Cohorts in Its Phase I/II Trial of TG ... GlobeNewswire (press release) NEW YORK, Feb. 11, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX) today announced that it has amended its Phase I/II study of single agent ublituximab to initiate its first expansion cohort following early signs of clinical activity. The ... |
